Kategorien
Aktien

Merck & Co. 77,17 USD -0,43% 

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN US58933Y1055
  • Merck & Co.
    Börse NYSE New York Stock Exchange
    ISIN US58933Y1055 WKN: A0YD8Q
    Symbol MRK
  • Merck & Co.
    Börse Xetra Frankfurt
    ISIN US58933YAW57
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Börse Düsseldorf
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Börse Hamburg
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Börse Berlin
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Gettex System der Börse München
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Börse Stuttgart
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Börse München
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Börse Frankfurt
    Symbol 6MK
    EUR
  • MERCK & CO. INC.
    Börse Quotrix System der Börse Düsseldorf
    Symbol 6MK
    EUR
  • Merck & Co.
    Börse BUE
    ISIN US58933Y1055
    USD
  • ISIN US58933YAT29
    USD
  • ISIN US58933YAR62
    MXN
  • USD
  • EUR
ISIN US58933Y1055
WKN A0YD8Q
Symbol MRK
Börse NYSE New York Stock Exchange Zeitzone: America/Argentina/Buenos_Aires
Marktkapitalisierung 150.086.000.000
Mitarbeiter 67.000

Aktionärsstruktur der Merck & Co.

237 News & Informationen zur Merck & Co. Aktie

  • South Street Advisors LLC Buys Eli Lilly and Co, Darling Ingredients Inc, Microsoft Corp, Sells Merck Inc, Verizon Communications Inc
    gurufocus.com

    South Street Advisors LLC Buys Eli Lilly and Co, Darling Ingredients Inc, Microsoft Corp, Sells Merck Inc, Verizon Communications Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Pediatric Vaccine Market Research Report 2021: Market is Expected to Reach $49.9 Billion in 2025 - Long-term Forecast to 2030
    prnewswire.com

    Global Pediatric Vaccine Market Research Report 2021: Market is Expected to Reach $49.9 Billion in 2025 – Long-term Forecast to 2030

    /PRNewswire/ — The

  • Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications And Growth Factors To 2030
    thestreet.com

    Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications And Growth Factors To 2030

    DUBLIN, Aug. 6, 2021 /PRNewswire/ — The “Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030” report has been added to

  • Global Depression Treatment Market (2020 to 2026) - Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others
    prnewswire.com

    Global Depression Treatment Market (2020 to 2026) – Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others

    /PRNewswire/ — The

  • Global Depression Treatment Market (2020 To 2026) - Featuring Allergen, Bausch Health Companies And Lief Therapeutics Among Others
    thestreet.com

    Global Depression Treatment Market (2020 To 2026) – Featuring Allergen, Bausch Health Companies And Lief Therapeutics Among Others

    DUBLIN, Aug. 5, 2021 /PRNewswire/ — The

  • Worldwide Protein Labeling Industry to 2026 - by Application, Labeling Method, Product and Region
    prnewswire.com

    Worldwide Protein Labeling Industry to 2026 – by Application, Labeling Method, Product and Region

    /PRNewswire/ — The

  • Merck : KEYTRUDA® (pembrolizumab) Significantly Prolonged Recurrence-Free Survival (RFS) Compared to Placebo as Adjuvant Therapy for...
    marketscreener.com

    Merck : KEYTRUDA® (pembrolizumab) Significantly Prolonged Recurrence-Free Survival (RFS) Compared to Placebo as Adjuvant Therapy for Patients With Stage II Resected High-Risk Melanoma in Phase 3 KEYNO

    US FDA Grants Priority Review to Merck’s Application for KEYTRUDA Based on These Data
    … | August 5, 2021

  • Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
    news.google.com

    Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

    Moderna releases second quarter earnings and clinical update

  • Marketmind: A time to taper By Reuters
    investing.com

  • Cutler Capital Management, LLC Buys South Jersey Industries Inc, First Southn BK Patterson GA, Agnico Eagle Mines, Sells South Jersey...
    gurufocus.com

    Cutler Capital Management, LLC Buys South Jersey Industries Inc, First Southn BK Patterson GA, Agnico Eagle Mines, Sells South Jersey Industries Inc, Albertsons Inc, Sempra Energy

    GuruFocus Article or News written by insider and the topic is about:

  • Celyad Oncology : Reports First Half 2021 Financial Results and Recent Business Highlights (Form 6-K)
    marketscreener.com

    Celyad Oncology : Reports First Half 2021 Financial Results and Recent Business Highlights (Form 6-K)

    Celyad Oncology Reports First Half 2021 Financial Results and Recent Business Highlights

    August 4, 2021, 10:00 p.m. CEST

    … | August 4, 2021

  • Stoneridge Investment Partners Llc Buys Zimmer Biomet Holdings Inc, Dollar Tree Inc, Baxter International Inc, Sells Nike Inc, Merck Inc,...
    gurufocus.com

    Stoneridge Investment Partners Llc Buys Zimmer Biomet Holdings Inc, Dollar Tree Inc, Baxter International Inc, Sells Nike Inc, Merck Inc, Wells Fargo

    GuruFocus Article or News written by insider and the topic is about:

  • Empire Life Investments Inc. Buys Facebook Inc, Merck Inc, Chevron Corp, Sells Alexion Pharmaceuticals Inc, Xylem Inc, Vontier Corp
    gurufocus.com

    Empire Life Investments Inc. Buys Facebook Inc, Merck Inc, Chevron Corp, Sells Alexion Pharmaceuticals Inc, Xylem Inc, Vontier Corp

    GuruFocus Article or News written by insider and the topic is about:

  • Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    thestreet.com

    Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    DUBLIN, Ireland, Aug. 03, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc NBRV, a biopharmaceutical company engaged in the commercialization and development

  • Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
    prnewswire.com

    Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR

    /PRNewswire/ — Oncolytic viruses are being increasingly used in cancer immunotherapy. A number of oncolytic viruses have been extensively studied in clinical…

  • Milestone Group, Inc. Buys BTC BlackRock Ultra Short-Term Bond ETF, Vanguard High Dividend Yield Indx ETF, Schlumberger, Sells iShares Core...
    gurufocus.com

    Milestone Group, Inc. Buys BTC BlackRock Ultra Short-Term Bond ETF, Vanguard High Dividend Yield Indx ETF, Schlumberger, Sells iShares Core U.S. Aggregate Bond ETF, Fidelity MSCI Real Estate Index ETF

    GuruFocus Article or News written by insider and the topic is about:

  • Wilkins Investment Counsel Inc Buys Autodesk Inc, Gartner Inc, Splunk Inc
    gurufocus.com

    Wilkins Investment Counsel Inc Buys Autodesk Inc, Gartner Inc, Splunk Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
    prnewswire.com

    Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others

    /PRNewswire/ — The “Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to…

  • Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
    markets.businessinsider.com

    Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others

    DUBLIN, July 30, 2021 /PRNewswire/ — The 'Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 202…

  • The Worldwide Contraceptives Industry is Expected to Reach $29.6 Billion by 2028
    prnewswire.com

    The Worldwide Contraceptives Industry is Expected to Reach $29.6 Billion by 2028

    /PRNewswire/ — The “Contraceptives Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, End User, Distribution Channel” report has been…

  • Merck & Co., Inc. 2021 Q2 - Results - Earnings Call Presentation (NYSE:MRK)
    seekingalpha.com

    Merck & Co., Inc. 2021 Q2 – Results – Earnings Call Presentation (NYSE:MRK)

    The following slide deck was published by Merck & Co., Inc.

  • Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer
    globenewswire.com

    Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer

    THE WOODLANDS, Texas, July 30, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that Craig Granowitz, M.D., Ph.D….

  • Paragon Capital Management Ltd Buys BTC BlackRock Ultra Short-Term Bond ETF, T-Mobile US Inc, JM Smucker Co, Sells Eastman Chemical Co,...
    gurufocus.com

    Paragon Capital Management Ltd Buys BTC BlackRock Ultra Short-Term Bond ETF, T-Mobile US Inc, JM Smucker Co, Sells Eastman Chemical Co, Invesco, Bank of America Corp

    GuruFocus Article or News written by insider and the topic is about:

  • WESPAC Advisors SoCal, LLC Buys Rio Tinto PLC, Goldman Sachs Group Inc, Thermo Fisher Scientific Inc, Sells Merck Inc, iShares Gold Trust,...
    gurufocus.com

    WESPAC Advisors SoCal, LLC Buys Rio Tinto PLC, Goldman Sachs Group Inc, Thermo Fisher Scientific Inc, Sells Merck Inc, iShares Gold Trust, Apple Inc

    GuruFocus Article or News written by insider and the topic is about:

  • U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44% By Investing.com
    investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44% By Investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44%

  • Merck & Co., Inc. (MRK) CEO Rob Davis on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Merck & Co., Inc. (MRK) CEO Rob Davis on Q2 2021 Results – Earnings Call Transcript

    Call start: 8:00 Call end: 9:09 Merck & Co., Inc.

  • Merck & Co taucht aus dem Corona-Sumpf auf - Merck & Co-Aktie in Rot
    finanzen.net

    Merck & Co taucht aus dem Corona-Sumpf auf – Merck & Co-Aktie in Rot

    Nach einem mauen Jahresstart kommt der US-Pharmakonzern Merck & Co langsam wieder in Schwung. 29.07.2021

  • Oliver Luxxe Assets LLC Buys Snap-on Inc, Boeing Co, Aon PLC, Sells Nike Inc, Cummins Inc, Merck Inc
    gurufocus.com

    Oliver Luxxe Assets LLC Buys Snap-on Inc, Boeing Co, Aon PLC, Sells Nike Inc, Cummins Inc, Merck Inc

    GuruFocus Article or News written by insider and the topic is about:

  • LATE BRIEFING - Unternehmen und Märkte -2-
    finanzen.net

    LATE BRIEFING – Unternehmen und Märkte -2-

    LATE BRIEFING – Unternehmen und Märkte -2- | Nachricht | finanzen.net

  • Merck Announces Appointment Of Cristal N. Downing As Chief Communications & Public Affairs Officer
    thestreet.com

    Merck Announces Appointment Of Cristal N. Downing As Chief Communications & Public Affairs Officer

    Merck MRK, known as MSD outside the United States and Canada, today announced that Cristal N. Downing has been appointed chief communications & public affairs

  • Monoclonal Antibodies Market to Reach $390.58 Bn, Globally at 10.2% CAGR by 2030: Says AMR
    prnewswire.com

    Monoclonal Antibodies Market to Reach $390.58 Bn, Globally at 10.2% CAGR by 2030: Says AMR

    /PRNewswire/ — According to the report the, global monoclonal antibodies market was pegged at $146.64 billion in 2020 and is estimated to reach $390.58…

  • Merck & Co. Inc. Stock Quote (U.S.: NYSE)
    marketwatch.com

    Merck & Co. Inc. Stock Quote (U.S.: NYSE)

    MRK | Complete Merck & Co. Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  • Merck (MRK) Q2 Earnings and Revenues Surpass Estimates
    zacks.com

    Merck (MRK) Q2 Earnings and Revenues Surpass Estimates

    Merck (MRK) delivered earnings and revenue surprises of 0.77% and 1.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Dow Futures 145 Pts Higher After Powell's Comments; Facebook Disappoints By Investing.com
    investing.com

    Dow Futures 145 Pts Higher After Powell's Comments; Facebook Disappoints By Investing.com

    Dow Futures 145 Pts Higher After Powell's Comments; Facebook Disappoints

  • Merck profit nearly halves on Organon spin off
    oann.com

    Merck profit nearly halves on Organon spin off

    Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.

  • Merck stock slips after adjusted profit matches expectations, while revenue beats
    marketwatch.com

    Merck stock slips after adjusted profit matches expectations, while revenue beats

    Shares of Merck & Co. Inc. undefined fell 0.9% in premarket trading Thursday, after the drug maker reported second-quarter adjusted profit that matched…

  • Merck profit nearly halves on Organon spin off By Reuters
    investing.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen Merck & Co. am höchsten gewichtet ist Insgesamt in 31 ETFs enthalten

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero